The role of telomerase activity in hepatocellular carcinoma

American Journal of Gastroenterology

Volumn 95, Issue 3, 2000, Pages 748-752

  Shimada, Mitsuo ^c   Hasegawa, Hirofumi ^a   Gion, Tomonobu ^a   Utsunomiya, Tohru ^a   Shirabe, Ken ^a   Takenaka, Kenji ^a   Otsuka, Teruhisa ^b   Maehara, Yoshihiko ^a,b   Sugimachi, Keizo ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; TELOMERASE;

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENDER; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; MULTIPLE CANCER; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROTEIN PRECURSORS; PROTHROMBIN; TELOMERASE;

EID: 0033994742     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00914-4     Document Type: Article

References (48)

1. Takenaka K., Kawahara N., Yamamoto K., et al. The results of 280 hepatic resections for hepatocellular carcinoma. Arch Surg. 131:1996;71-76.
2. Shimada M., Takenaka K., Fujiwara Y., et al. Factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg. 85:1998;195-198.
3. Shimada M., Matsumata T., Taketomi A., et al. Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery. 115:1994;703-706.
4. Shimada M., Takenaka K., Gion T., et al. Prognosis of recurrent hepatocellular carcinoma A 10-year surgical experience in Japan . Gastroenterology. 111:1996;720-726.
5. Shimada M., Takenaka K., Taguchi K., et al. Prognostic factors of repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg. 227:1998;80-85.
6. Takenaka K., Adachi E., Nishizaki T., et al. Possible multicentric occurrence of hepatocellular carcinoma A clinicopathological study . Hepatology. 19:1994;889-894.
7. Tsuda H., Hirohashi S., Shimosato Y., et al. Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology. 95:1988;1664-1666.
8. Sakamoto M., Hirohashi S., Tsuda H., et al. Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern. Am J Surg Pathol. 13:1989;1064-1067.
9. Hsu H.C., Chiou T.J., Chen J.Y., et al. Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules. Hepatology. 13:1991;923-928.
10. Tsuda H., Oda T., Sakamoto M., et al. Different pattern of chromosomal allele loss in multiple hepatocellular carcinomas as evidence of their multifocal origin. Cancer Res. 52:1992;1504-1509.
11. Adachi E., Maeda T., Matsumata T., et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology. 108:1995;768-775.
12. Ko S., Nakajima Y., Kanehiro H., et al. Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis. Ann Surg. 224:1996;591-595.
13. Miyagawa S., Kawasaki S., Makuuchi M. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection Tumor multicentricity in cirrhotic liver with hepatitis C . Hepatology. 24:1996;307-310.
14. Kumada T., Nakano S., Takeda I., et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology. 25:1997;87-92.
15. Greider C.W., Blackburn E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 43:1985;405-413.
16. Greider C.W., Blackburn E.H. A telomere sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature. 337:1989;331-337.
17. Yu G.L., Bradley J.D., Attardi L.D., et al. In vivo alteration of telomere sequence and senescence caused by mutated Tetrahymena telomerase RNAs. Nature. 344:1990;126-132.
18. Feng J., Funk W.D., Wang S.S., et al. The RNA component of human telomerase. Science. 269:1995;1236-1241.
19. Wright W.E., Shay J.W. Telomere positional effects and the regulation of cellular senescence. Trends Genet. 8:1992;193-197.
20. Kim N.W., Piatyszek M.A., Orowse K.R., et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
21. Tahara H., Nakanishi T., Kitamoto M., et al. Telomerase activity in human liver tissues Comparison between chronic liver disease and hepatocellular carcinomas . Cancer Res. 55:1995;2734-2736.
22. Chadeneau C., Hay K., Hirte H.W., et al. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 55:1955;2533-2536.
23. Hiyama E., Yokoyama T., Tatsumoto N., et al. Telomerase activity in gastric cancer. Cancer Res. 55:1995;3258-3262.
24. Hiyama E., Hiyama K., Yokoyama T., et al. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med. 1:1995;249-255.
25. Hiyama K., Hiyama E., Ishioka S., et al. Telomerase activity in small-cell and non-small cell lung cancers. J Natl Cancer Inst. 87:1995;895-902.
26. Counter C.M., Gupta J., Harley C.B., et al. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 85:1995;2315-2320.
27. Nakashio R., Kitamoto M., Tahara H., et al. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int J Cancer. 74:1997;141-147.
28. Kojima H., Yokosuka O., Imazeki F., et al. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology. 112:1997;493-500.
29. Urabe Y., Nouso K., Higashi T., et al. Telomere length in human liver diseases. Liver. 16:1996;293-297.
30. Nouso K., Urabe Y., Higashi T., et al. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer. 78:1996;232-236.
31. Miura N., Horikawa I., Nishimoto A., et al. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Gen Cyto. 93:1997;56-62.
32. Suda T., Isokawa O., Aoyagi Y., et al. Quantitation of telomerase activity in HCC A possible aid for a predictor of recurrent disease in the remnant liver . Hepatology. 27:1998;402-406.
33. The general rules for the clinical and pathological study of primary liver cancer, 3rd ed. 1992;Kanehara, Tokyo.
34. Kaplan G.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
35. 2)/E in the logrank test for survival data on tumor incidence data. Biometrics. 29:1973;579-584.
36. Cox D.R. Regression models and life tables. JR Stat Soc Ser B. 34:1972;187-220.
37. Blackburn E.H. Structure and function of telomeres. Nature. 350:1991;569-573.
38. Moyzis R.K., Buckingham J.M., Cram L.S., et al. A highly conserved repetitive DNA sequence (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA. 85:1988;6622-6626.
39. Meyne J., Ratliff R.L., Moyzis R.K. Conservation of the human telomere sequence (TTAGGG)n among vertebrates. Proc Natl Acad Sci USA. 86:1989;7049-7053.
40. Zakian V.A. Structure and function of telomeres. Annu Rev Genet. 23:1989;579-604.
41. de Lange T., Shiue L., Myers R.M., et al. Structure and variability of human chromosome ends. Mol Cell Biol. 10:1990;518-527.
42. Allsopp R.C., Vaziri H., Patterson C., et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA. 89:1992;10114-10118.
43. Lindsey J., McGill N.I., Lindsey L.A., et al. In vivo loss of telomeric repeats with age in humans. Mutat Res. 256:1991;45-48.
44. Hastie N.D., Dempster M., Dunlop M.G., et al. Telomere reduction in human colorectal carcinoma and with aging. Nature. 346:1990;866-868.
45. Harley C.B., Villeponteau B. Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev. 5:1995;249-255.
46. Shimada M., Takenaka K., Fujiwara Y., et al. Des-γ-carboxy prothrombin and α-fetoprotein positive status as a new prognostic indicator of hepatocellular carcinoma after hepatic resection. Cancer. 78:1996;2094-2100.
47. Suehiro T., Matsumata T., Itasaka H., et al. Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma. Surgery. 117:1995;682-691.
48. Edmondson H.A., Steiner P.E. Primary carcinoma of the liver A study of 100 cases among 48,900 necropsies . Cancer. 7:1954;462-503.